These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients.
    Author: Goldstein G, Kremer AB, Barnes L, Hirsch RL.
    Journal: J Pediatr; 1987 Dec; 111(6 Pt 2):1046-50. PubMed ID: 3316579.
    Abstract:
    The monoclonal antibody OKT3 was previously shown to be superior to conventional high-dose steroid therapy for reversal of acute rejection of renal allografts. Furthermore, OKT3 was effective in reversing acute renal or hepatic allograft rejection that was resistant to treatment with steroids, anti-thymocyte globulin, or both. Our analysis demonstrates that OKT3 is also effective in pediatric patients in reversing acute rejection of renal allografts (rescue treatment) or hepatic allografts (primary or rescue treatment).
    [Abstract] [Full Text] [Related] [New Search]